A detailed history of Forefront Analytics, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Forefront Analytics, LLC holds 3,883 shares of ABT stock, worth $445,613. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,883
Holding current value
$445,613
% of portfolio
0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $388,571 - $458,698
3,883 New
3,883 $442,000
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $37,097 - $43,665
383 Added 14.58%
3,009 $304,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $249,627 - $292,851
2,626 New
2,626 $288,000
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $2,679 - $3,430
-35 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$62.82 - $91.86 $2,198 - $3,215
35 New
35 $2,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.